Company Encyclopedia
View More
name
DEEJ
000423.SZ
Dong-E-E-Jiao Co.,Ltd. engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China. Its products include Ejiao, a Chinese tonic herbal medicine; compound donkey-hide gelatin paste; a donkey-hide gelatin cake under Peach Blossom Princess name; instant donkey-hide gelatin powder; donkey-hide gelatin, meat, and pineapple puree under the Zhuangben brand name; and brain and kidney nourishing oral liquid, as well as medical insurance products, such as tortoise shell glue and deer antler glue. The company was founded in 1952 and is based in Liaocheng, China.
3.159 T
000423.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
PharmaceuticalsIndustry
Industry Ranking10/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE16.90%A
    • Profit Margin27.42%A
    • Gross Margin74.58%A
  • Growth ScoreC
    • Revenue YoY4.61%C
    • Net Profit YoY10.45%C
    • Total Assets YoY0.26%C
    • Net Assets YoY0.40%C
  • Cash ScoreC
    • Cash Flow Margin364.75%C
    • OCF YoY4.61%C
  • Operating ScoreC
    • Turnover0.48C
  • Debt ScoreA
    • Gearing Ratio21.77%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    DEEJ released its performance for the first three quarters, with a net profit attributable to the parent company of 1.274 billion yuan, a year-on-year increase of 10.53%

    According to the Zhitong Finance APP, Dong'e Ejiao released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 4.766 billion yuan, a year-on-year increase of 4.41%. The net profit attributable to shareholders of the listed company was 1.274 billion yuan, a year-on-year increase of 10.53%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.155 billion yuan, a year-on-year increase of 8.23%

    Zhitong·
    SZ
    000423
    +0.80%
    Zhitong·
    SZ
    000423
    +0.80%

    China Resources Pharmaceutical: DEEJ's net profit for the first three quarters is 1.277 billion yuan, an increase of 10.77% year-on-year

    According to the Zhitong Finance APP, China Resources Pharmaceutical announced its Dong'e Ejiao performance for the nine months ending September 30, 2025, with total operating revenue of RMB 4.766 billion, an increase of 4.41% year-on-year; net profit of RMB 1.277 billion, an increase of 10.77% year-on-year

    Zhitong·
    SZ
    000423
    +0.80%
    Zhitong·
    SZ
    000423
    +0.80%

    Guojin Securities: Terminal demand is gradually recovering, and the prosperity of the pharmaceutical and health industry is expected to rise

    Guotai Junan Securities released a research report indicating that the pharmaceutical and healthcare industry is expected to improve in the second half of 2025, with performance in certain left-side sectors such as ophthalmology, dentistry, and pharmacies expected to improve. The performance pressure from the 2024 earnings base is decreasing quarter by quarter, inventory at traditional Chinese medicine companies continues to be digested, and the execution time for centralized procurement has been announced, leading to an overall positive performance. Key companies to focus on include Aier, Shanghai Pharma, CR Sanjiu, and DEEJ

    Zhitong·
    SZ
    300015
    +0.62%
    SZ
    000999
    +0.21%
    SZ
    000423
    +0.80%
    Zhitong·
    SZ
    300015
    +0.62%
    SZ
    000999
    +0.21%
    SZ
    000423
    +0.80%

    DEEJ: In the first half of 2025, a dividend of 12.7 yuan will be distributed for every 10 shares, with the equity registration date set for September 2, 2025

    DEEJ announced that the profit distribution plan for the first half of 2025 is as follows: Based on a total share capital of 643,976,824 shares, excluding the repurchased shares of 553,661 shares, the total number of shares participating in profit distribution is 643,423,163 shares. A cash dividend of 12.700919 yuan will be distributed for every 10 shares to all shareholders. The equity registration date is September 2, 2025, and the ex-dividend date is September 3, 2025

    Zhitong·
    SZ
    000423
    +0.80%
    Zhitong·
    SZ
    000423
    +0.80%

    DEEJ: Will focus on promoting Southeast Asia export business

    DEEJ recently stated at the performance briefing that it will focus on promoting its Southeast Asia export business, aiming to break through key aspects of quality and certification in the future, expand channels with pharmaceutical qualifications, and simultaneously accelerate the pace of cultural export to achieve coordinated development of product output and cultural dissemination

    Zhitong·
    SZ
    000423
    +0.80%
    Zhitong·
    SZ
    000423
    +0.80%
    © 2025 Longbridge｜Disclaimer